share_log

Chardan Capital Maintains Buy on Coya Therapeutics, Maintains $14 Price Target

Chardan Capital Maintains Buy on Coya Therapeutics, Maintains $14 Price Target

Chardan Capital維持對Coya Therapeutics的買入,維持14美元的目標股價
Benzinga ·  04/29 08:05

Chardan Capital analyst Keay Nakae maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $14 price target.

Chardan Capital分析師Keay Nakae維持Coya Therapeutics(納斯達克股票代碼:COYA)的買入並維持14美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論